LINDA HAYSLETT
Allopathic & Osteopathic Physicians|Internal Medicine LARGO, FL NPI 1295069847
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine FL NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$94.41
- Category: General Payments
- Program years: PY2018
- Record count: 7
- As of (CMS publication): 2026-01-23
Latest program year (PY2018): $94.41 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2018) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $94.41 | 7 |
By paying entity
Latest program year (PY2018) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $44.21 | 3 |
| Janssen Pharmaceuticals, Inc | $16.75 | 1 |
| GlaxoSmithKline, LLC. | $11.48 | 1 |
| Acerta Pharma LLC | $11.41 | 1 |
| Amgen Inc. | $10.56 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2018 | $94.41 | 7 |
Records — PY2018 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 549904585 | Janssen Pharmaceuticals, Inc | $16.75 | 10/23/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 562350165 | AstraZeneca Pharmaceuticals LP | $11.41 | 03/02/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 567588963 | Amgen Inc. | $10.56 | 02/28/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 596189789 | GlaxoSmithKline, LLC. | $11.48 | 09/28/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 608216175 | Novartis Pharmaceuticals Corporation | $16.04 | 02/06/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 608216187 | Novartis Pharmaceuticals Corporation | $14.86 | 06/07/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 608216193 | Novartis Pharmaceuticals Corporation | $13.31 | 10/09/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.